Incidence and Risk Factors of Acute and Chronic GVHD
Dr Sophie Paczesny details the incidence of graft versus host disease (GVHD) in patients receiving allogeneic transplants, and Dr Yi-Bin Chen describes the differing risk factors for acute and chronic GVHD.
EP: 1.Indications for Allogeneic Stem Cell Transplantation in the Treatment of Hematological Malignancies
Now Viewing
EP: 2.Incidence and Risk Factors of Acute and Chronic GVHD
EP: 3.Common Prophylaxis Regimens for GVHD
EP: 4.Diagnosis and Stratification of Acute and Chronic GVHD
EP: 5.Frontline Treatment Options for Acute GVHD
EP: 6.Emerging Strategies for the Treatment of Acute GVHD
EP: 7.The Importance of Early Treatment of Chronic GVHD
EP: 8.Treatment Options for Steroid-Refractory Chronic GVHD
EP: 9.Key Investigational Approaches for Acute and Chronic GVHD
EP: 10.The Evolving Field of GVHD Treatment
Related Videos
Related Content
